Clinical Trial Update: Molecular Subtyping of Triple-negative Breast Cancer and African Ancestry-related Immunogenicity

View source ↗

Summary

A completed clinical trial investigating molecular subtypes of triple-negative breast cancer and potential immunogenic differences related to African ancestry.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Triple-negative Breast Cancer

Snippet

Sponsor: Nova Scotia Health Authority | Conditions: Triple Negative Breast Cancer | Status: COMPLETED